From: Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells
piRNA | Cancer type | piRNA expression | Detection method | Association of higher piRNA expression with | Notes, references | |
---|---|---|---|---|---|---|
Survival | Metastasis | |||||
piR-Hep1 | Hepatocellular carcinoma | Increased | NGS, RT-qPCR | Â | Â | [96] |
piR-001773 | Prostate cancer | Increased | NGS, RT-qPCR |  | ↑ | [97] |
piR-017184 | Prostate cancer | Increased | NGS, RT-qPCR |  | ↑ | [97] |
piR-017724 | Hepatocellular carcinoma | Decreased | RT-qPCR | ↑ |  | Lower expression associated with stage III-IV tumors and poor survival [98]. |
piR-021285 | Breast cancer | Not evaluated |  |  |  | Single nucleotide polymorphism (SNP)- rs1326306G > T in piR-021285 is associated with increased risk of breast cancer [99]. |
piR-18 | Colorectal cancer | Decreased | RT-qPCR | Â | Â | [100] |
piR-651 | Breast cancer | Increased | RT-qPCR | Â | Â | [101] |
Lung cancer (NSCLC) | Increased | RT-qPCR, Northern Blot, in situ hybridization | Â | Â | [102] | |
Hodgkin lymphoma | Â | RT-qPCR | Â | Â | Higher expression in affected lymph nodes associated with limited response to first line therapy, shorter disease-free survival and overall survival (OS) [103]. | |
piR-823 | Multiple myeloma | Increased | RT-qPCR | Â | Â | Higher expression correlates with advanced stages [55]. |
Colorectal cancer | Increased | RT-qPCR | Â | Â | Higher expression correlates with advanced stages [104, 105]. | |
Gastric cancer | Decreased | RT-qPCR | Â | Â | [106] | |
Esophageal cancer | Increased | RT-qPCR |  | ↑ | Higher expression associated with lymph node metastasis [107]. | |
Renal cell carcinoma | Decreased | RT-qPCR | ↓ |  | Lower expression compared to healthy tissue. However, higher expression correlates with shorter disease-free survival [108]. | |
piR-1245 | Colorectal cancer | Increased | NGS | ↓ | ↑ | Expression correlates with metastasis, stage of the disease and lower OS [109]. |
piR-1742 | Renal cell carcinoma | Increased | Microarray | ↓ | ↑ | Increased expression is associated with high tumor grade, advanced stage of the disease and lower survival. Downregulation led to lower proliferation, migration, enhanced apoptosis and tumor growth in vivo. piR-1742 affects cancer cell behavior via the USP8/MUC12 axis [110]. |
piR-2158 | Breast cancer | Decreased | NGS, RT-qPCR |  |  | PiR-2158 is decreased in ALDH+ cancer stem cells (CSC) compared to ALDH- cancer cells. Upregulation led to lower cell proliferation, migration and suppression of EMT and stemness markers [81]. |
piR-4987 | Breast cancer | Increased | NGS, RT-qPCR |  | ↑ | Higher expression associated with lymph node metastasis [111]. |
piR-8041 | Glioblastoma | Decreased | Microarray, RT-qPCR | Â | Â | [112] |
piR-9491 | Glioblastoma | Decreased | NGS, RT-qPCR | Â | Â | [113] |
piR-12488 | Glioblastoma | Decreased | NGS, RT-qPCR | Â | Â | [113] |
piR-13643 | Papillary thyroid carcinoma | Increased | NGS, RT-qPCR | Â | Â | [114] |
piR-14633 | Cervical cancer | Increased | NGS, RT-qPCR | Â | Â | piR-14633 involved in the regulation of METTL14/CYP1B1 [115]. |
piR-18849 | Colorectal cancer | Increased | NGS, RT-qPCR |  | ↑ | Associated with low degree of differentiation and lymph node metastases [116]. |
piR-19521 | Colorectal cancer | Increased | NGS, RT-qPCR | Â | none | Associated with low degree of differentiation [116]. |
piR-20365 | Breast cancer | Increased | NGS, RT-qPCR | Â | Â | [111] |
piR-20485 | Breast cancer | Increased | NGS, RT-qPCR | Â | Â | [111] |
piR-20582 | Breast cancer | Increased | NGS, RT-qPCR | Â | Â | [111] |
piR-21238 | Papillary thyroid carcinoma | Increased | NGS, RT-qPCR | Â | Â | [114] |
piR-25783 | Ovarian cancer | Increased | ISH | ↓ | ↑ | High expression in cancer tissue associated with high-grade serous ovarian cancer, advanced stage, omentum and appendix metastasis and worse overall survival. Ovarian cancer cells secrete piR-25783 in exosomes contributes to the formation of a premetastatic niche by activating the TGF-β/SMAD2/SMAD3 pathway in omentum fibroblasts [117]. |
piR-30188 | Gliomas | Decreased | Microarray, RT-qPCR | Â | Â | [118] |
piR-30473 | DLBCL | Increased | Microarray | ↓ |  | Higher expression associated with low OS [119]. |
piR-30924 | Clear cell renal cell carcinoma | Increased | Microarray | Â | Â | Upregulation is associated with lymph node metastasis. HIgher expression in primary tumor correlates with recurrence and shorter OS [120]. |
piR-31115 | Clear cell renal cell carcinoma | Increased | NGS, RT-qPCR | Â | Â | [121] |
piR-31470 | Prostate cancer | Increased | RT-qPCR | Â | Â | piR-31470 and PIWIL4 contribute to the inactivation of GSTP1 expression via epigenetic modifications [122]. |
piR-34536 | Clear cell renal cell carcinoma | Decreased | RT-qPCR | ↑ |  | Derived from mitochondrial DNA, lower levels associated with worse cancer specific and OS independent of age, grade and pT and M stage [123]. |
piR-34871 | Lung cancer | Variable expression | RT-qPCR | Â | Â | [124] |
piR-35127 | Lung cancer | Variable expression | RT-qPCR | Â | Â | [124] |
piR-36249 | Testicular cancer | Decreased | RT-qPCR | Â | Â | [125] |
piR-36712 | Breast cancer | Decreased | RT-qPCR | ↑ | ↓ | Low levels associated with worse PFS and lymph node metastasis, piR-36712 functions as a tumor suppressor. It targets SEPW1P, a retroprocessed pseudogene of SEPW1 and thus inhibits SEPW1 through competition with its regulators miR-7 and miR-324 leading to increased p53, p21 and E-cadherin expression and downregulation of Slug [126]. |
piR-38756 | Clear cell renal cell carcinoma | Increased | Microarray | ↓ | ↑ | Upregulation is associated with lymph node metastasis. Higher expression in primary tumor correlates with recurrence and shorter OS [120]. |
piR-46545 | Lung cancer | Variable expression | RT-qPCR | Â | Â | [124] |
piR-51810 | Clear cell renal cell carcinoma | Decreased | RT-qPCR | ↑ |  | Derived from mitochondrial DNA, lower levels associated with worse PFS, cancer specific and OS independent of age, grade and pT and M stage [123]. |
piR-52200 | Lung cancer | Variable expression | RT-qPCR | Â | Â | [124] |
piR-54265 | Colorectal cancer | Increased | RT-qPCR | ↓ |  | Tissue levels of piRNA-54265 are higher in advanced and metastatic colorectal cancer and are associated with shorter PFS and OS. piRNA-54265 binds PIWIL2 and via activation of STAT3 signaling promotes the proliferation, metastasis and chemoresistance of colorectal cancer cells [73]. |
piR-55490 | Lung cancer | Decreased | RT-qPCR | ↓ |  | piR-55490 targets 3'UTR of the mTOR mRNA [65]. |
piR-57125 | Clear cell renal cell carcinoma | Decreased | NGS, RT-qPCR, Microarray | ↑ | ↓ | Lower expression associated with lymph node metastasis. Lower expression correlates with recurrence and shorter OS [120, 127]. |
piR-164586 | Lung cancer (NSCLC) | Increased | NGS, RT-qPCR | Â | Â | Low expression associated with stage II and III [128]. |
piR-211106 | Lung adenocarcinoma | Decreased | NGS, RT-qPCR | Â | Â | [129] |